Aggressive immunosuppression minimization shortens BK viremia, does not improve outcome, but increases the risk of De Novo donor specific antibodies in kidney recipients

Devresse, Arnaud; Tinel, C; Vermorel, A; Snanoudj, R; Morin, L; Avettand-Fenoel, V; Amrouche, L; Scemla, A; Zuber, J; Legendre, C; Rabant, M; Anglicheau, D

Aggressive immunosuppression minimization shortens BK viremia, does not improve outcome, but increases the risk of De Novo donor specific antibodies in kidney recipients

Devresse, Arnaud

;

Tinel, C

;

Vermorel, A

;

Snanoudj, R

;

Anglicheau, D

;et.al.

(2018) American Transplant Congress — Location: Washington State Convention Center, Seattle, USA (2.June.2018)

Files

DevresseetalAggressiveimmunosuppressionminimizationshortensBKviremiaABSTRACT.pdf

Closed Access
Adobe PDF
219.19 KB

Request a copy

Details

Authors

Devresse, ArnaudUCLouvain
Author
Tinel, C
Author
Vermorel, A
Author
Snanoudj, R
Author
Anglicheau, D
Author

Affiliations

Citations

APA
Chicago
FWB

Devresse, A., Tinel, C., Vermorel, A., Snanoudj, R., Morin, L., Avettand-Fenoel, V., Amrouche, L., Scemla, A., Zuber, J., Legendre, C., Rabant, M., & Anglicheau, D. (2018). Aggressive immunosuppression minimization shortens BK viremia, does not improve outcome, but increases the risk of De Novo donor specific antibodies in kidney recipients. American Journal of Transplantation, 18(S4), 299. https://hdl.handle.net/2078.5/50698 (Original work published 2018)